PMS
PMS, licence 80039601: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Vitazan Herbs and Vitamins Inc
- NPN or DIN-HM
- 80039601
- Status
- Active licence
- Licence date
- 13 February 2013
- Revision date
- 31 May 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Actaea racemosa Source : Extrait de racine Extraction ratio : 12:1 Dry plant equivalent : 480 mg Potency : 2.5 % Triterpene glycosides | 40.0 mg | Not calculated |
| Taraxacum officinale Source : Extrait de racine Extraction ratio : 10:1 Dry plant equivalent : 3000 mg Potency : 3.0 % Flavonoids | 300.0 mg | Not calculated |
| Angelica sinensis Source : Extrait de racine Extraction ratio : 20:1 Dry plant equivalent : 5000 mg Potency : 1.0 % Z-ligustilide | 250.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Eau purifiée, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Black cohosh is used in Herbal Medicine to help relieve premenstrual symptoms; used in Herbal Medicine to help relieve the pain associated with menstruation. Chasteberry is used in Herbal Medicine to help relieve premenstrual symptoms and is used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities. Dandelion is traditionally used in Herbal Medicine as an alternative to help relieve dermatological conditions.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039601
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.